PEG 3350 Market Research Report Information by Product Type (Powder, Bowel Preparation Kit) by Age (Pediatric, Adult, and Geriatric) by Application (Constipation, Medical Tests, [Colonoscopy and Barium Enema X-Ray Examination], and Surgery) by Distribution Channel (Online Pharmacy, Offline Pharmacy), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
Market Overview
The PEG 3350 market was valued at USD 1.92 billion in 2023. The PEG 3350 Market industry is expected to increase from USD 2.08 billion in 2024 to USD 3.71 billion by 2032, with a compound yearly growth rate (CAGR) of 6.63% over the forecast period (2024-2032). The increased prevalence of colon cancer in India and other emerging countries, as well as an increase in strategic activities, are driving market expansion.
The incidence of colon cancer is rising worldwide. For example, according to an article published in Lancet Regional Health Southeast Asia, colon cancer is the seventh most frequent cancer in India, with 65,358 new cases expected in 2021. The global incidence of colon cancer has been increasing, and it is now 19.5 per 100,000 people, with 15.2 per 100,000 in India. Similarly, changing behaviors, such as consuming a calorie-rich and low-fiber diet, eating too much red meat and processed foods, and being physically inactive. In addition, the age-sex-adjusted rates of colon cancer in India have risen by 20.6%, with a high increase among persons under the age of 50.
As a result, the increased incidence of colon cancer is expected to drive up demand for PEG 3350. This cumulative prevalence of colon cancer, together with changing lifestyle choices such as rising alcohol and tobacco usage, rising smoking rates, and bad dietary habits among the population, is predicted to boost the PEG 3350 markets over the forecast period.
Market Segment insights
The PEG 3350 market segmentation is based on powder and bowel prep kits.
The market is divided into three segments based on age: pediatric, adult, and geriatric.
The PEG 3350 Market is segmented by application, which includes constipation and medical testing. and surgery.
The market is segmented based on distribution channels, which include online and offline pharmacies.
Regional insights
The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. The North American PEG 3350 market had the biggest market share in 2022. This is attributable to the increased occurrence of colorectal cancer, as well as other ailments like diabetes, cancer, and neurological disorders in North America.
The PEG 3350 market in Europe is the second-largest due to the increased frequency of colorectal cancer and the region's increasing acceptance of sedentary lifestyles. Furthermore, the Germany PEG 3350 Market was ascribed with the greatest market share and is predicted to be the fastest-growing market in the European area.
The Asia-Pacific PEG 3350 market is predicted to develop significantly between 2024 and 2032. This is attributed to an increasing senior population, the adoption of sedentary lifestyles and physical inactivity, and the increased prevalence of colorectal cancer in Asia-Pacific countries. Furthermore, China PEG 3350 Market is estimated to hold the greatest market share, followed by India. The PEG 3350 market is predicted to be the fastest-growing in the Asia-Pacific region.
The rest of the world is divided into three regions: the Middle East, Africa, and Latin America. The PEG 3350 Market in the aforementioned regions is expected to expand due to a lack of understanding regarding the proper diet. Furthermore, according to the report, colorectal cancer is on the rise in the Middle East in both young and older adults, and it causes frequent constipation in children, supporting the region's market expansion.
Major Players
Teva Pharmaceutical Industries Ltd (Israel), LGM Pharma (US), McKesson Corporation (US), Sisco Research Laboratories Pvt. Ltd. (India), BASF SE (Germany), Merck KGaA (US), Bayer AG (Germany), Lupin Pharmaceuticals, Inc (India), Breckenridge Pharmaceutical, Inc. (US), and Pendopharm (Canada) are among the key players in the PEG 3350 Market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL PEG 3350 MARKET, FOR POWDER, BY REGION, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL PEG 3350 MARKET, FOR BOWEL PREPARATION KIT, BY REGION, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL PEG 3350 MARKET, FOR PEDIATRIC, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL PEG 3350 MARKET, FOR ADULT, BY REGION, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL PEG 3350 MARKET, FOR GERIATRIC, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL PEG 3350 MARKET, FOR CONSTIPATION, BY REGION, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL PEG 3350 MARKET, FOR MEDICAL TESTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL PEG 3350 MARKET, FOR COLONOSCOPY, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL PEG 3350 MARKET, FOR BARIUM ENEMA X-RAY EXAMINATION, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL PEG 3350 MARKET, FOR SURGERY, BY REGION, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL PEG 3350 MARKET, FOR ONLINE PHARMACY, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL PEG 3350 MARKET, FOR OFFLINE PHARMACY, BY REGION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL: PEG 3350 MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 20 NORTH AMERICA: PEG 3350 MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 21 NORTH AMERICA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 22 NORTH AMERICA: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 23 NORTH AMERICA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 24 NORTH AMERICA: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)
TABLE 25 NORTH AMERICA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 26 US: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 27 US: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 28 US: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 29 US: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)
TABLE 30 US: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 31 CANADA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 32 CANADA: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 33 CANADA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 34 CANADA: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)
TABLE 35 CANADA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 36 EUROPE: PEG 3350 MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 37 EUROPE: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 38 EUROPE: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 39 EUROPE: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 40 EUROPE: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 41 EUROPE: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 42 GERMANY: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 43 GERMANY: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 44 GERMANY: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 45 GERMANY: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 46 GERMANY: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 47 FRANCE: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 48 FRANCE: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 49 FRANCE: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 50 FRANCE: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 51 FRANCE: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 52 UK: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 53 UK: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 54 UK: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 55 UK: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)
TABLE 56 UK: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 57 ITALY: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 58 ITALY: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 59 ITALY: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 60 ITALY: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 61 ITALY: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 62 SPAIN: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 63 SPAIN: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 64 SPAIN: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 65 SPAIN: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 66 SPAIN: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 67 REST OF EUROPE: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 68 REST OF EUROPE: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)
TABLE 69 REST OF EUROPE: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 70 REST OF EUROPE: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 71 REST OF EUROPE: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 72 ASIA-PACIFIC: PEG 3350 MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 73 ASIA-PACIFIC: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 74 ASIA-PACIFIC: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 75 ASIA-PACIFIC: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 76 ASIA-PACIFIC: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 77 ASIA-PACIFIC: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 78 CHINA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 79 CHINA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 80 CHINA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 81 CHINA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 82 CHINA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 83 INDIA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 84 INDIA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 85 INDIA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 86 INDIA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 87 INDIA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 88 JAPAN: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 89 JAPAN: PEG 3350 MARKET, BY AGE, 2018-2030(USD BILLION) (USD BILLION)
TABLE 90 JAPAN: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 91 JAPAN: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 92 JAPAN: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 93 SOUTH KOREA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 94 SOUTH KOREA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 95 SOUTH KOREA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 96 SOUTH KOREA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 97 SOUTH KOREA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 98 AUSTRALIA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 99 AUSTRALIA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 100 AUSTRALIA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 101 AUSTRALIA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 102 AUSTRALIA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 103 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 104 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 105 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 106 REST OF ASIA PACIFIC: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 107 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 108 REST OF THE WORLD: PEG 3350 MARKET, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 109 REST OF THE WORLD: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 110 REST OF THE WORLD: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 111 REST OF THE WORLD: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 112 REST OF THE WORLD: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 113 REST OF THE WORLD: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 114 MIDDLE EAST: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 115 MIDDLE EAST: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 116 MIDDLE EAST: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 117 MIDDLE EAST: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 118 MIDDLE EAST: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 119 AFRICA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 120 AFRICA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 121 AFRICA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 122 AFRICA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 123 AFRICA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 124 LATIN AMERICA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 125 LATIN AMERICA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)
TABLE 126 LATIN AMERICA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 127 LATIN AMERICA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)
TABLE 128 LATIN AMERICA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)
TABLE 129 MAJOR PLAYERS IN THE GLOBAL PEG 3350 MARKET
TABLE 130 MOST ACTIVE PLAYER IN THE GLOBAL PEG 3350 MARKET
TABLE 131 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 132 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS/SERVICES OFFERED
TABLE 133 LGM PHARMA: PRODUCTS/SERVICES OFFERED
TABLE 134 MCKESSON CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 135 SISCO RESEARCH LABORATORIES PVT. LTD.: PRODUCTS/SERVICES OFFERED
TABLE 136 BASF SE: PRODUCTS/SERVICES OFFERED
TABLE 137 MERCK KGAA: PRODUCTS OFFERED
TABLE 138 BAYER AG: PRODUCTS OFFERED
TABLE 139 BAYER AG: KEY DEVELOPMENTS
TABLE 140 LUPIN PHARMACEUTICALS, INC.: PRODUCTS OFFERED
TABLE 141 BRECKENRIDGE PHARMACEUTICAL, INC.: PRODUCTS OFFERED
TABLE 142 PENDOPHARM: PRODUCTS OFFERED
TABLE 143 PENDOPHARM: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL PEG 3350 MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PEG 3350 MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL PEG 3350 MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PEG 3350 MARKET
FIGURE 9 GLOBAL PEG 3350 MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD BILLION)
FIGURE 10 GLOBAL PEG 3350 MARKET, BY AGE, 2022 & 2032 (USD BILLION)
FIGURE 11 GLOBAL PEG 3350 MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)
FIGURE 12 GLOBAL PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2032 (USD BILLION)
FIGURE 13 GLOBAL: PEG 3350 MARKET, BY REGION 2022 & 2032 (USD BILLION)
FIGURE 14 GLOBAL: PEG 3350 MARKET SHARE (%), BY REGION, 2022
FIGURE 15 NORTH AMERICA: PEG 3350 MARKET SHARE (%), BY COUNTRY 2022
FIGURE 16 EUROPE: PEG 3350 MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 17 ASIA-PACIFIC: PEG 3350 MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 18 REST OF THE WORLD: PEG 3350 MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PEG 3350 MARKET
FIGURE 21 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MCKESSON CORPORATION: SWOT ANALYSIS
FIGURE 24 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BASF SE: SWOT ANALYSIS
FIGURE 26 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MERCK KGAA: SWOT ANALYSIS
FIGURE 28 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 BAYER AG: SWOT ANALYSIS
FIGURE 30 LUPIN PHARMACEUTICALS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 LUPIN PHARMACEUTICALS, INC.: SWOT ANALYSIS
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們